General Pharmacodynamics
Opioid receptor antagonists have the specific ability to block $\mu$-, $\delta$-, and $\kappa$-receptors in the nervous system. Their primary pharmacological value lies in their ability to effectively reverse clinical manifestations induced by narcotic analgesics.
Administration of this drug class reverses the following opioid effects:
- Analgesia (pain relief);
- Euphoria (pathologically elevated mood);
- Respiratory depression (the most dangerous adverse effect of opioids);
- Sedation and miosis (pupillary constriction).
Naloxone: Emergency Rescue Medication
Chemically, naloxone is a phenanthrene derivative. In clinical practice, it acts as a pure competitive antagonist of opioid receptors.
- Primary Indication: Acute intoxication (overdose) with narcotic analgesics. The drug competitively displaces opioid molecules from binding sites in the respiratory center, restoring adequate ventilation.
- Pharmacokinetics: Administered primarily via intravenous injection for the fastest possible onset of action. It features a relatively short duration of action, ranging from 2 to 4 hours.
- Spectrum of Activity: Successfully reverses overdose symptoms caused by both "pure" agonists and agonist-antagonist agents.
- Important Clinical Feature: Naloxone exhibits clinically reduced efficacy when reversing buprenorphine overdoses. This occurs because buprenorphine forms an exceptionally tight bond with opioid receptors that is difficult to disrupt, even with high doses of the antagonist.
Naltrexone: Maintenance Therapy for Dependencies
Unlike naloxone, naltrexone has a pronounced prolonged duration of action and is used for scheduled maintenance therapy in addiction medicine.
- Pharmacokinetics: The drug is highly effective when administered orally (by mouth). Its therapeutic effect lasts up to 24 hours.
- Treatment of Opioid Use Disorder: By reliably blocking the receptors, naltrexone completely prevents the euphoria associated with opioid use. The patient no longer experiences "pleasure" from the drug, which helps extinguish the addiction.
- Treatment of Alcohol Use Disorder: The drug is also widely used to treat alcohol dependence, as it significantly reduces alcohol craving.
- Adverse Effects: Administering naltrexone to patients with an established physical drug dependence (prior to detoxification) inevitably precipitates acute withdrawal syndrome (abstinence syndrome).
Differential Pharmacology of Opioid Agents
In pharmacology, it is critically important to distinguish pure antagonists from other drug groups that interact with opioid receptors. The following categories must be clearly differentiated:
- Pure antagonists (naloxone, naltrexone) — block receptors without producing any intrinsic activation effects.
- Agonist-antagonists (e.g., nalbuphine) — stimulate certain types of opioid receptors while blocking others, possessing intrinsic analgesic potential.
- Full agonists (e.g., pantopon/opium alkaloids) — classical agents that fully stimulate receptors and produce the entire spectrum of opioid effects, including dependence.